CNCR ETF
CNCR ETF
$9.02
Range Cancer Therapeutics ETF
AUM$7M
TER0.79%
Holdings67
See how much of CNCR you already own
See how much of CNCR you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
CNCR ETF Overview
CNCR ETF (Range Cancer Therapeutics ETF) is managed by Loncar Investments with $6.9M in net assets. CNCR expense ratio is 0.79%, holding 67 positions across various sectors. Inception date: 2015-10-13.
CNCR performance shows a YTD return of -20.21%. The 1-year return is -32.21% and the 5-year return is -13.59%.
CNCR top holdings include a diversified portfolio. Go to all CNCR holdings, CNCR sectors, or CNCR dividends.
CNCR can be compared against other funds. Use CNCR overlap to find shared positions, or CNCR vs another fund for a side-by-side view. CNCR alternatives are available via the screener, along with tax-loss harvesting opportunities.